San Francisco, CA (PRWEB) October 24, 2008
If the current economic climate isn't encouraging organizations to tighten their belts, they aren't paying attention. Even industry leaders in the lucrative biotech and pharmaceutical arenas are searching for ways to trim budgets and improve their profit margins. Sunesis Pharmaceuticals is giving cost-conscious companies the rare opportunity to purchase late-model lab equipment at pre-owned prices.
Sunesis has contracted with EquipNet, the world's leading provider of surplus asset management, to oversee the two -phase liquidation project. Premium items from the South San Francisco facility will first be offered on a pre-auction basis on the EquipNet.com MarketPlace™. Any remaining equipment will be sold at a live webcast auction on Thursday, November 6. Pre-registered buyers can place bids from the comfort of their own offices.
In many cases, the Sunesis offering will allow companies to buy top-of-the-line pre-owned equipment for less than they would have to pay for mid-range new items. The project offerings include late-model laboratory and analytical equipment--a great find for local and global lab/R&D firms looking to upgrade equipment at their facilities.
"The project is a perfect example of how EquipNet's Cascading Liquidation strategy is the perfect fit for managing surplus assets for our clients," notes EquipNet CEO and President Roger Gallo. "Buyers will have the opportunity to negotiate the purchase highly sought after equipment right up until the auction event."
About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the pharmaceutical, biotech, chemical, and consumer packaged goods industries, such as GlaxoSmithKline, AstraZeneca, Unilever, Eastman Chemical, and many others. EquipNet's vision is to revolutionize the way companies manage their surplus assets by maximizing financial returns and minimizing the risks associated with idle capital assets. For more information, please visit: http://www.EquipNet.com.
# # #